Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapy
Open Access
- 1 January 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 40 (2) , 353-358
- https://doi.org/10.1016/s0360-3016(97)00573-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Five-year observations concerning lobular carcinoma in situCancer, 1996
- Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patientCancer, 1994
- What is the significance of a lobular carcinoma in situ (LCIS) component in women treated with breast conserving therapy (BCT) for early stage breast cancer?International Journal of Radiation Oncology*Biology*Physics, 1993
- Regional nodal irradiation in the conservative treatment of breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Conservation therapy for breast cancers other than infiltrating ductal carcinomaCancer, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Breast Carcinoma In SituArchives of Surgery, 1989
- Chemosuppression of Breast Cancer with Tamoxifen: Laboratory Evidence and Future Clinical InvestigationsCancer Investigation, 1988
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breastCancer, 1978
- Lobular carcinomain Situ of the breast:An approach to rational treatmentCancer, 1977